Mindray Medical (迈瑞医疗)

Shenzhen-listed global medical device company producing patient monitors, in-vitro diagnostics, and ultrasound systems deployed in 190+ countries.

Shenzhen, ChinaAPACAdvantage marketLatest Jan 22, 2026
Monitoring Status
Signals (30d)
1
Most active type
Partnership
Primary channel
Primary theme
Patient monitoring
Latest update
Jan 22, 2026
vs. prior 30 days
Rising

Key Changes (30d)

Mar 18Verified

Mindray and Medtronic expand their patient monitoring technology partnership to include ambulatory surgery centers across the United States.

Mindray Medical and Medtronic Expand Partnership to U.S. Ambulatory Surgery Centers

Source Language Distribution

Language distribution will appear as more signals are collected from diverse sources.

Strategic themes and signal pattern

Strategic Themes

Patient monitoringIn-vitro diagnosticsUltrasound imagingGlobal medical device expansionHospital equipment

Recent Signal Pattern

Most frequent signal typePartnership
Activity Trend (30d)
Rising
0
1
Prev 30dLast 30d
Sources tracked2
Total signals tracked1

Why this company matters

Mindray is the most globally successful Chinese medical device company, with meaningful market share in both emerging and developed markets. Its patient monitoring business competes directly with Philips and GE Healthcare. Mindray's growth trajectory is a leading indicator of Chinese medical device companies' ability to move upmarket globally.

  • Key domain relevance: Patient monitoring, In-vitro diagnostics, Ultrasound imaging
  • Active monitoring with 1 signals in the last 30 days across 2 tracked sources.

Channel Context

Channel context will be available once this company is assigned to a primary channel.

Market Context

This company operates in one of SigFact's strongest advantage markets, where official updates often surface first in local language.

See recent signals in this market

Continue monitoring Mindray Medical (迈瑞医疗)

Follow this company, add it to your watchlist, or explore its signal stream to stay informed.

Add to Watchlist